Skip to main content
HairCited

Innovation in Alopecia Areata.

Luiza Kalil, Brett King
Review Dermatologic clinics 2025 5 citations
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D39542562'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Type d'étude
Review
Population
Patients with alopecia areata (review)
Intervention
Innovation in Alopecia Areata. None
Comparateur
None
Critère de jugement principal
Alopecia areata treatment outcomes
Direction de l'effet
Positive
Risque de biais
Unclear

Abstract

Advances in understanding of AA have led to the first approved therapies for this disease, and in the past two years, there have been three medicines approved for the treatment of severe alopecia areata. There are numerous clinical trials of novel therapeutics underway across the spectrum of AA.

En bref

None

Used In Evidence Reviews

Similar Papers